| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | B932PAQ1BQ |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 2 | D016403 | ClinicalTrials |
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Hepatitis C, Chronic | 1 | D019698 | ClinicalTrials |
| Carcinoma, Hepatocellular | 1 | D006528 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1036730-42-3 |
| ChEMBL | CHEMBL2108680 |
| FDA SRS | B932PAQ1BQ |
| Guide to Pharmacology | 7692 |
CONTENTS